Cancer Recurrence Blood Test Market Sees Dominant Player Emerge
Cancer recurrence blood test company achieves dominant market position & financial growth, showing investor confidence in this healthcare sector.
14 May 2026
New Blood Test Detects Multiple Cancers and Diseases
New low-cost blood test detects multiple cancers & diseases using DNA methylation patterns. Identifies disease origin with high specificity.
06 May 2026
Blood Test Identifies Early Dementia Markers
New blood test uses gut microbiome markers for early dementia detection, achieving over 80% accuracy in identifying mild cognitive impairment.
04 May 2026
Blood Test Identifies Alzheimer's Biomarker Years Before Scans
New blood test for pTau217 detects Alzheimer's indicators years before symptoms, aiding early risk identification and clinical trial design.
02 May 2026
